Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: J Allergy Clin Immunol. 2015 Oct 28;137(2):601–609.e8. doi: 10.1016/j.jaci.2015.08.042

FIG 1.

FIG 1

Study design. Four groups of subjects, group 1 (patients with birch pollen allergy with AD, n = 15), group 2 (patients with birch pollen allergy with rhinoconjunctivitis without AD, n = 5), group 3 (allergic patients without birch pollen allergy and without AD, n = 5), and group 4 (nonallergic subjects, n = 5), were subjected to SPTs and APTs.